US based CDC is interested in assisting to select corona vaccine recipients in Bangladesh

The US Institute of Health and Research Institute (CDC) said it was keen to assist Bangladesh with its expertise in prioritizing potential anti-COVID 19 vaccine recipients. This issue is likely to emerge as a “big challenge” in the coming days.

Dr. Michael Friedman, Country Director of the Centers for Disease Control and Prevention (CDC) in Dhaka, said this in a recent interview with BSS.

  Learn about the COVID-19 pandemic from News Hour  

Friedman, a physician and health expert, said it would be difficult for Bangladesh to get more than one million doses of vaccine in the first six months after a vaccine is developed.

He said that despite the success of the immunization process for children, it is important to prioritize who will get the vaccine in the first phase as there is no adult immunization program in Bangladesh.

“Vaccination of children and immunization of adults is not the same thing,” Friedman said, adding that vaccinating a large number of adults would be challenging.

Friedman said Bangladesh could use the opportunity to gain more cooperation to get adequate vaccines in the global competition.

He lauded the capabilities and quality of pharmaceutical companies in Bangladesh, saying there were technical challenges in vaccine production and it was time-consuming to achieve this capability.

Beximco Pharma, Bangladesh’s leading pharmaceutical company, has already signed a memorandum of understanding with the Seram Institute of India to supply 30 million doses of vaccine to Bangladesh.

U.S. experts also suggest that Bangladesh could look for potential vaccines from Russia and China to prevent Covid 19 for its most vulnerable populations.

Follow News Hour
News Hour Correspondent

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments
Scroll Up
%d bloggers like this: